Drug to prevent breast cancer
Women at increased risk of breast cancer could benefit from a risk-reducing drug, after it was licensed in a new use to help prevent the disease. Anastrozole, which has been used for many years as a breast cancer treatment, has been licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) as a preventive option. The drug has been shown in trials to reduce the incidence of the disease in post-menopausal women at increased risk of the disease by almost 50%.